ArticleClinical epigenetics2021

Different methylation signatures at diagnosis in patients with high-risk myelodysplastic syndromes and secondary acute myeloid leukemia predict azacitidine response and longer survival.

M Cabezón et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.